Mitchell Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Mitchell Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-45,897	Closed	-$2.72M	–	146
2021 Q3	$2.72M	Sell	45,897 -248	-0.5%	-$16.3K	0.61%	58
2021 Q2	$3.08M	Buy	46,145 +1,380	+3%	+$90K	0.68%	51
2021 Q1	$2.83M	Buy	44,765 +3,645	+9%	+$227K	0.69%	52
2020 Q4	$2.55M	Buy	41,120 +2,861	+7%	+$176K	0.64%	56
2020 Q3	$2.31M	Buy	38,259 +1,067	+3%	+$64.2K	0.67%	51
2020 Q2	$2.19M	Buy	37,192 +293	+0.8%	+$17.5K	0.7%	50
2020 Q1	$2.06M	Buy	36,899 +8,178	+28%	+$500K	0.8%	41
2019 Q4	$1.84M	Buy	28,721 +7,433	+35%	+$426K	0.59%	63
2019 Q3	$1.08M	Buy	+21,288	New	+$1M	0.36%	76

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mitchell Capital Management's BMY Position: Q4 2021 in Review

Mitchell Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 45,897 shares — an estimated $2.72M sold.

Mitchell Capital Management first reported a position in BMY in Q3 2019 and held it in 9 quarters. The position peaked at $3.08M in Q2 2021. 2,445 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

Mitchell Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
Mitchell Capital Management sold 45,897 Bristol-Myers Squibb shares in Q4 2021, an estimated $2.72M.
Mitchell Capital Management first reported a position in Bristol-Myers Squibb in Q3 2019 and held it in 9 quarters.
Mitchell Capital Management's Bristol-Myers Squibb position peaked at $3.08M in Q2 2021.
2,445 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Mitchell Capital Management's 13F filing for Q4 2021, filed 28 Jan 2022.